Ann: Positive Results from IHL-675 (ARDS) animal study, page-91

I think I mentioned yesterday that my hope was that this would be the start of a re rate and for the upward trend to continue I would be happy. I dont expect IHL to go nuts, (unless of course FDA grants emergency use). They need to keep delivering results like these in the other trials etc and just keep ticking boxes. Drug discovery takes time.
Each to their own, that is the good thing about the market, it is horses for courses.
I really like the way IHL is starting to track, the other good thing is that with OSA - if our drug helps reduce OSA by say 30-40% it will be a huge out come, same with TBI - reduce it by 20-30 percent and it huge, the same with ARDS- making it better for 15-20% could mean you live as opposed to die.
Anyway I will sign out again for a few weeks. Be nice to each other.